136 related articles for article (PubMed ID: 3490132)
1. Drug interactions with macrolide antibiotics: specificity of pseudo-suicide inhibition and induction of cytochrome P-450.
Dansette PM; Delaforge M; Sartori E; Beaune P; Jaouen M; Mansuy D
Adv Exp Med Biol; 1986; 197():155-62. PubMed ID: 3490132
[TBL] [Abstract][Full Text] [Related]
2. Some erythromycin derivatives are strong inducers in rats of a cytochrome P-450 very similar to that induced by 16 alpha-pregnenolone carbonitrile.
Sartori E; Delaforge M; Mansuy D; Beaune P
Biochem Biophys Res Commun; 1985 May; 128(3):1434-9. PubMed ID: 3873941
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro effects of a new macrolide antibiotic roxithromycin on rat liver cytochrome P-450: comparison with troleandomycin and erythromycin.
Delaforge M; Sartori E; Mansuy D
Chem Biol Interact; 1988; 68(3-4):179-88. PubMed ID: 3265076
[TBL] [Abstract][Full Text] [Related]
4. Identification of the cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450p.
Wrighton SA; Maurel P; Schuetz EG; Watkins PB; Young B; Guzelian PS
Biochemistry; 1985 Apr; 24(9):2171-8. PubMed ID: 3888267
[TBL] [Abstract][Full Text] [Related]
5. Dual effects of macrolide antibiotics on rat liver cytochrome P-450. Induction and formation of metabolite-complexes: a structure-activity relationship.
Delaforge M; Jaouen M; Mansuy D
Biochem Pharmacol; 1983 Aug; 32(15):2309-18. PubMed ID: 6603844
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of dihydroergotamine by a cytochrome P-450 similar to that involved in the metabolism of macrolide antibiotics.
Delaforge M; Rivière R; Sartori E; Doignon JL; Grognet JM
Xenobiotica; 1989 Nov; 19(11):1285-95. PubMed ID: 2618081
[TBL] [Abstract][Full Text] [Related]
7. In vivo effects of erythromycin, oleandomycin and erythralosamine derivatives on hepatic cytochrome P-450.
Delaforge M; Sartori E
Biochem Pharmacol; 1990 Jul; 40(2):223-8. PubMed ID: 2375764
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of cytochrome P-450 by a troleandomycin metabolite. Protective role of glutathione.
Pessayre D; Tinel M; Larrey D; Cobert B; Funck-Brentano C; Babany G
J Pharmacol Exp Ther; 1983 Mar; 224(3):685-91. PubMed ID: 6600790
[TBL] [Abstract][Full Text] [Related]
9. In vitro interaction of rat liver cytochromes P-450 with erythromycin, oleandomycin and erythralosamine derivatives. Importance of structural factors.
Sartori E; Delaforge M; Mansuy D
Biochem Pharmacol; 1989 Jul; 38(13):2061-8. PubMed ID: 2735945
[TBL] [Abstract][Full Text] [Related]
10. Effects of macrolide antibiotics on drug metabolism in rats and in humans.
Pessayre D
Int J Clin Pharmacol Res; 1983; 3(6):449-58. PubMed ID: 6381341
[TBL] [Abstract][Full Text] [Related]
11. Drug interactions and hepatitis produced by some macrolide antibiotics.
Pessayre D; Larrey D; Funck-Brentano C; Benhamou JP
J Antimicrob Chemother; 1985 Jul; 16 Suppl A():181-94. PubMed ID: 3877043
[TBL] [Abstract][Full Text] [Related]
12. Decrease in a constitutive form of cytochrome P-450 by macrolide antibiotics.
Miura T; Iwasaki M; Komori M; Ohi H; Kitada M; Mitsui H; Kamataki T
J Antimicrob Chemother; 1989 Oct; 24(4):551-9. PubMed ID: 2515189
[TBL] [Abstract][Full Text] [Related]
13. Self-induction by oleandomycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450. Comparison with troleandomycin.
Pessayre D; Descatoire V; Tinel M; Larrey D
J Pharmacol Exp Ther; 1982 Apr; 221(1):215-21. PubMed ID: 6977641
[No Abstract] [Full Text] [Related]
14. Specific drug binding to rat liver cytochrome P-450 isozymes induced by pregnenolone-16 alpha-carbonitrile and macrolide antibiotics. Implications for drug interactions.
Sartori E; Delaforge M
Chem Biol Interact; 1990; 73(2-3):297-307. PubMed ID: 2107034
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin.
Yamazaki H; Shimada T
Drug Metab Dispos; 1998 Nov; 26(11):1053-7. PubMed ID: 9806945
[TBL] [Abstract][Full Text] [Related]
16. Immunochemical similarity of P-450 HFLa, a form of cytochrome P-450 in human fetal livers, to a form of rat liver cytochrome P-450 inducible by macrolide antibiotics.
Kitada M; Igoshi N; Kamataki T; Itahashi K; Imaoka S; Komori M; Funae Y; Rikihisa T; Kanakubo Y
Arch Biochem Biophys; 1988 Jul; 264(1):61-6. PubMed ID: 3395131
[TBL] [Abstract][Full Text] [Related]
17. Modulation of rat hepatic CYP3A1 induction by the interferon inducer polyinosinic acid-polycytidylic acid (polyic).
Delaporte E; Cribb AE; Renton KW
Drug Metab Dispos; 1993; 21(3):520-3. PubMed ID: 7686458
[TBL] [Abstract][Full Text] [Related]
18. Formation of inactive cytochrome P-450 Fe(II)-metabolite complexes with several erythromycin derivatives but not with josamycin and midecamycin in rats.
Larrey D; Tinel M; Pessayre D
Biochem Pharmacol; 1983 May; 32(9):1487-93. PubMed ID: 6860368
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P-450 complex formation by dirithromycin and other macrolides in rat and human livers.
Lindstrom TD; Hanssen BR; Wrighton SA
Antimicrob Agents Chemother; 1993 Feb; 37(2):265-9. PubMed ID: 8452357
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the macrolide antibiotic inducible cytochrome P-450 LM3c in the metabolism of midazolam by microsomal fractions prepared from rabbit liver.
Fabre G; Crevat-Pisano P; Dragna S; Covo J; Barra Y; Cano JP
Biochem Pharmacol; 1988 May; 37(10):1947-53. PubMed ID: 3259880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
